American Journal of Clinical Pathology · 2004 · 117 citations · 30 references
MedicineOncologyPathologyHepatologyMetastasisMolecular OncologyHepatic PathologyHepatobiliary CancerHepatobiliary PathologyHepatocellular CarcinomaLiver CancerLiver MetastasisColonic AdenocarcinomaHepatic MalignancyHepatic TumorsHepatocellular Carcinoma MetastasisMetastatic Hepatocellular CarcinomaMetastatic Liver TumorsMicroarray AnalysisTissue Microarray Analysis
Hepatocyte paraffin 1 (Hep Par 1) is a monoclonal antibody developed from hepatic tissue from a failed liver allograft. Several studies have shown that Hep Par 1 is a useful marker to differentiate hepatocellular carcinoma (HCC) from other types of adenocarcinoma metastatic to the liver. The aim of our study was the systematic investigation of the epidemiology of Hep Par 1 expression in 3,940 tissue samples using the tissue microarray technique. Strong Hep Par 1 expression was found most frequently in 35 (73%) of 48 HCCs. In nonhepatic tumors, strong Hep Par 1 expression was detected in adenocarcinoma of the lung (2/50), gallbladder (3/31), pancreas (2/48), stomach (3/74), small intestine (1/11), adenoma of the colon with high-grade dysplasia (1/49), adrenal gland carcinoma (1/6), paraganglioma (1/9), and malignant melanoma (2/48). Our data suggest that Hep Par 1 is a highly specific marker for HCC, although several nonhepatic tumors occasionally can show some Hep Par 1 positivity.
30
Tissue microarrays for high-throughput molecular profiling of tumor specimens
Juha Kononen, Lukas Bubendorf, Anne Kallionimeni et al. · Nature Medicine · 1998 · 4.1K citations
Tissue Microarrays for Rapid Linking of Molecular Changes to Clinical Endpoints
J. Torhorst, Christoph Bucher, Juha Kononen et al. · American Journal Of Pathology · 2001 · 569 citations · Full text
Tissue microarrays for gene amplification surveys in many different tumor types.
Peter Schraml, Juha Kononen, Lukas Bubendorf et al. · PubMed · 1999 · 439 citations